- Home
- OPHC vs GNTA Comparison
OPHC vs GNTA Comparison
Compare OPHC & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPHC | GNTA |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.3M | 41.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPHC | GNTA |
|---|---|---|
| Price | $4.34 | $1.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.9K | ★ 106.2K |
| Earning Date | 02-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.25 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $43,818,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.34 | ★ N/A |
| Revenue Growth | ★ 26.98 | N/A |
| 52 Week Low | $3.53 | $1.35 |
| 52 Week High | $5.04 | $10.00 |
Technical Indicators
Market Signals| Indicator | OPHC | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 60.21 | 31.02 |
| Support Level | $4.11 | $1.80 |
| Resistance Level | $4.34 | $1.77 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 76.49 | 8.82 |
Price Performance
Historical ComparisonAbout OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.